etodolac has been researched along with Spinal Stenosis in 2 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
Spinal Stenosis: Narrowing of the spinal canal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the effect of limaprost, an oral prostaglandin (PG) E1 derivative, on health-related quality of life (HRQOL) in patients with symptomatic lumbar spinal stenosis (LSS), compared to etodolac, a NSAID." | 5.14 | The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis. ( Anamizu, Y; Hoshi, K; Kishimoto, J; Kobayashi, A; Kunogi, J; Matsudaira, K; Nakamura, K; Seichi, A; Takeshita, K; Yamazaki, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsudaira, K | 1 |
| Seichi, A | 1 |
| Kunogi, J | 1 |
| Yamazaki, T | 1 |
| Kobayashi, A | 1 |
| Anamizu, Y | 1 |
| Kishimoto, J | 1 |
| Hoshi, K | 1 |
| Takeshita, K | 1 |
| Nakamura, K | 1 |
| Takahashi, J | 1 |
| Kobayashi, H | 1 |
| Wakabayashi, S | 1 |
| Deguchi, M | 1 |
| Ito, H | 1 |
| Mogami, Y | 1 |
| Tanikawa, H | 1 |
| Nakagawa, H | 1 |
| Moriya, H | 1 |
| Ashizawa, R | 1 |
| Takahara, K | 1 |
| Kinoshita, H | 1 |
| Tateiwa, Y | 1 |
| Misawa, H | 1 |
| Tsutsumimoto, T | 1 |
| Nakakohji, T | 1 |
| Yuzawa, Y | 1 |
| Sawaumi, A | 1 |
| Hidai, Y | 1 |
| Matsuda, S | 1 |
| Nakamura, I | 1 |
| Toba, S | 1 |
| Kamimura, M | 1 |
| Nakane, T | 1 |
| Hirabayashi, H | 1 |
| Hashidate, H | 1 |
| Ogihara, N | 1 |
| Mukaiyama, K | 1 |
| Kato, H | 1 |
| Ohtsuka, K | 1 |
1 trial available for etodolac and Spinal Stenosis
| Article | Year |
|---|---|
The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alprostadil; Anti-Inflammatory Agents, Non-Ster | 2009 |
1 other study available for etodolac and Spinal Stenosis
| Article | Year |
|---|---|
The effect of a prostaglandin E1 derivative on the symptoms and quality of life of patients with lumbar spinal stenosis.
Topics: Activities of Daily Living; Aged; Alprostadil; Chi-Square Distribution; Cyclooxygenase 2 Inhibitors; | 2013 |